Antigenics, Inc

Merck & Co Inc


P.O. Box 100, One Merck Drive
Whitehouse Station, NJ 08889

USA


Phone: (908) 423-1000
Fax: (908) 735-1253
Web Site: http://www.merck.com/

 

A. Company Profile

 

Merck (NYSE:MRK) is one of world's leading pharmaceutical companies. The company's product portfolio includes innovative treatments across a wide range of therapeutic areas. There are extensive discovery and development programs in the field of oncology at Merck.

 

B. Products

 

 

Product Pipelines

 

 

Product

 

 

Indication

 

Clinical Status

Emend (aprepitant)

Nausea and vomiting after cancer chemotherapy

 

Phase III

 

Gardasil

 

Cervical cancer

 

Phase III

 

VX-680

 

Various tumors

 

Phase I

 

1. VX-680

 

VX-680 is an Aurora kinase inhibitor. Aurora kinase is implicated in the onset and progression of many different human cancers. As enzymes specific for and essential to cell growth and division, Aurora kinases hold the potential to be important control points for slowing the growth and spread of tumors.

 

VX-680 is being codeveloped by Merck and Vertex.